New potent and selective PDE10A inhibitors for the treatment of schizophrenia

被引：0
|
作者：
Malamas, Michael S.
Ni, Yike
Erdei, James
Fan, Kristi
Hoefgen, Norbert
Stange, Hans
Schindler, Rudolf
Grunwald, Christian
Egerland, Ute
Langen, Barbara
Hage, Thorsten
Kronbach, Thomas
Grauer, Steven
Harrison, Boyd
Robichaud, Albert
Marquis, Karen
Comery, Thomas
Dunlop, John
Pangalos, Menelas
Brandon, Nicholas
机构：
来源：
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY | 2010年 / 240卷
关键词：
D O I：
暂无
中图分类号：
O6 [化学];
学科分类号：
0703 ;
摘要：
3-MEDI
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Rapid approach to identification of a PDE10A tracer to support development of PDE10A inhibitors in preclinical and clinical studies
    Harrington, Essa Hu
    Ma, Ji
    Biorn, Christopher
    Lester-Zeiner, Dianna
    Cho, Robert
    Rumfelt, Shannon
    Kunz, Roxanne
    Nixey, Thomas
    Michelsen, Klaus
    Miller, Silke
    Shi, Jianxia
    Della Puppa, Geraldine Hill
    Talreja, Santosh
    Able, Jessica
    Hwang, Dah-Ren
    Slifstein, Mark
    Easwaramoorthy, Balu
    Hitchcock, Stephen
    Porter, Amy
    Allen, Jennifer
    Immke, David
    Treanor, James
    Chen, Hang
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2013, 246
  • [22] Discovery of novel potent imidazo[1,2-b]pyridazine PDE10a inhibitors
    Meegalla, Sanath K.
    Huang, Hui
    Illig, Carl R.
    Parks, Daniel J.
    Chen, Jinsheng
    Lee, Yu-Kai
    Wilson, Kenneth J.
    Patel, Sharmila K.
    Cheung, Wing S.
    Lu, Tianbao
    Kirchner, Thomas
    Askari, Hossein B.
    Geisler, John
    Patch, Raymond J.
    Gibbs, Alan C.
    Rady, Brian
    Connelly, Margery
    Player, Mark R.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2016, 26 (17) : 4216 - 4222
  • [23] Discovery of AMG 579, a novel phosphodiesterase 10 (PDE10A) inhibitor, as a potential treatment for schizophrenia
    Allen, Jennifer R.
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2014, 247
  • [24] PDE10 Inhibitors as Potential Treatment for Schizophrenia
    Abdel-Magid, Ahmed F.
    ACS MEDICINAL CHEMISTRY LETTERS, 2013, 4 (02): : 161 - 162
  • [25] Pyrazoloquinolines as PDE10A inhibitors: Discovery of a tool compound
    McElroy, William T.
    Tan, Zheng
    Basu, Kallol
    Yang, Shu-Wei
    Smotryski, Jennifer
    Ho, Ginny D.
    Tulshian, Deen
    Greenlee, William J.
    Mullins, Deborra
    Guzzi, Mario
    Zhang, Xiaoping
    Bleickardt, Carina
    Hodgson, Robert
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2012, 22 (03) : 1335 - 1339
  • [26] MALEIMIDES DERIVATIVES AS NEW PDE10A INHIBITORS OR PUTATIVE DRUGS FOR CNS DISEASES
    Gonzalez Garcia, A.
    Garcia Fernandez, A. M.
    Brea Floriani, J. M.
    Martinez Gil, A.
    Gil Ayuso-Gontan, C.
    Loza Garcia, M. I.
    Cadavid Torres, M. I.
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2015, 117 : 29 - 30
  • [27] Discovery of potent, selective, and metabolically stable 4-(pyridin-3-yl)cinnolines as novel phosphodiesterase 10A (PDE10A) inhibitors
    Hu, Essa
    Kunz, Roxanne K.
    Rumfelt, Shannon
    Chen, Ning
    Buerli, Roland
    Li, Chun
    Andrews, Kristin L.
    Zhang, Jiandong
    Chmait, Samer
    Kogan, Jeffrey
    Lindstrom, Michelle
    Hitchcock, Stephen A.
    Treanor, James
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2012, 22 (06) : 2262 - 2265
  • [28] Triazoloquinazolines as a novel class of phosphodiesterase 10A (PDE10A) inhibitors
    Kehler, Jan
    Ritzen, Andreas
    Langgard, Morten
    Petersen, Sebastian Leth
    Farah, Mohamed M.
    Bundgaard, Christoffer
    Christoffersen, Claus Tornby
    Nielsen, Jacob
    Kilburn, John Paul
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2011, 21 (12) : 3738 - 3742
  • [29] Patented PDE10A inhibitors: novel compounds since 2007
    Kehler, Jan
    Kilburn, John Paul
    EXPERT OPINION ON THERAPEUTIC PATENTS, 2009, 19 (12) : 1715 - 1725
  • [30] Preclinical Characterization of PDE10A Inhibitors as Putative Antipsychotic Agents
    Schmidt, Christopher J.
    BIOLOGICAL PSYCHIATRY, 2012, 71 (08) : 17S - 17S
12345